Control of warfarin therapy
- PMID: 2692014
- PMCID: PMC2429184
- DOI: 10.1136/pgmj.65.767.611
Control of warfarin therapy
Comment in
-
Control of warfarin therapy.Postgrad Med J. 1990 Feb;66(772):155. doi: 10.1136/pgmj.66.772.155. Postgrad Med J. 1990. PMID: 2349193 Free PMC article. No abstract available.
Similar articles
-
Induction of liver cytochrome P450s by Danshen-Gegen formula is the leading cause for its pharmacokinetic interactions with warfarin.J Ethnopharmacol. 2014 Jul 3;154(3):672-86. doi: 10.1016/j.jep.2014.04.047. Epub 2014 May 14. J Ethnopharmacol. 2014. PMID: 24832110
-
[Fifty years of clinical use of warfarin].Invest Clin. 2010 Jun;51(2):269-87. Invest Clin. 2010. PMID: 20928982 Spanish.
-
Warfarin therapy. 2.N Engl J Med. 1970 Oct 8;283(15):801-3. doi: 10.1056/NEJM197010082831508. N Engl J Med. 1970. PMID: 4917271 Review. No abstract available.
-
Oral anticoagulation with warfarin is significantly influenced by steroids and CYP2C9 polymorphisms in children with cancer.Pediatr Blood Cancer. 2008 Mar;50(3):710-3. doi: 10.1002/pbc.21133. Pediatr Blood Cancer. 2008. PMID: 17226852 Clinical Trial.
-
Current concepts of warfarin therapy.Arch Intern Med. 1986 Mar;146(3):581-4. Arch Intern Med. 1986. PMID: 3513725 Review.
Cited by
-
Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.Br J Gen Pract. 1993 Apr;43(369):152-4. Br J Gen Pract. 1993. PMID: 8323801 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical